TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | 0 | -4 | -34 | -46 | -47 | -26 |
| S | %wins | 50 | 50 | 50 | 100 | 100 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/9/10 16:23 | 8/6/10 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Zayas Ricardo | MA | O | SVP,Oper | S.m | 0 | 0.0528 | 14 | -6 | -53 | 5 | D | -28 | -30 | -18 | 2 | -13 | -14 | -14 | -1 | -1 | -8 | -18 | -46 | -42 | -49 |
6/9/10 16:50 | 6/8/10 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Zayas Ricardo | MA | O | SVP,Oper | S.dm | -39 | 32.46 | 11 | -1 | -10 | 11 | D | -18 | -39 | -16 | -7 | -12 | 2 | 0 | -4 | 3 | 8 | 11 | -21 | -50 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |